Advertisement

An index case of primary osseous PEComa in a paediatric craniofacial skeleton

  • Jason DiabEmail author
  • Tomas O’Neill
  • Lynette Moore
  • Stephen Santoreneos
  • Walter Flapper
Case Report
  • 4 Downloads

Abstract

Perivascular epithelioid cell tumours, known as PEComas, are a family of tumours with immunoreactive melanocytic and smooth muscle markers. They are a rare heterogeneous group in adulthood and childhood with primary osseous PEComas representing an even rarer subgroup. The clinical behaviour is not well understood and the treatment options vary. We present an index case of a primary osseous PEComa of the craniofacial skeleton in a 3-year-old girl.

Level of evidence: Level V, diagnostic; therapeutic; risk/prognostic study.

Keywords

Craniofacial Neoplasms PEComa 

Notes

Acknowledgements

We would like to express our gratitude to the members of the Australian Craniofacial Unit.

Compliance with ethical standards

Funding

There was no funding for this research publication.

Conflict of interest

Jason Diab, Tomas O’Neill, Lynette Moore, Stephen Santoreneos, and Walter Flapper declare that they have no conflict of interest.

Ethical approval

The human research and ethics committee has approved this research publication with no restrictions.

Informed consent

Informed consent has been obtained for this research publication.

Patient consent

The patient provided written consent for the use of her image.

References

  1. 1.
    Thyway KH, Fisher C (2015) PEComa: morphology and genetics of a complex tumour family. Ann Diagn Pathol 19:359–368CrossRefGoogle Scholar
  2. 2.
    Malinowska I, Kwiatkowski DJ, Weiss S, Martignoni G, Netto G, Argani P (2012) Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction. Am J Surg Pathol 36(5):783–784CrossRefGoogle Scholar
  3. 3.
    Chang KL, Folpe AL (2001) Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors. Adv Anat Pathol 8(5):273–275CrossRefGoogle Scholar
  4. 4.
    Folpe AL, Kwiatkowski DJ (2010) Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol 41:1–15CrossRefGoogle Scholar
  5. 5.
    Yamashita K, Fletcher C (2010) PEComa presenting in bone: clinicopathologic analysis of 6 cases and literature review. AM J Surg Pathol 34(11):1623–1629Google Scholar
  6. 6.
    Bleeker JS, Quevedo JF, Folpe AL (2012) “Malignant” perivascular epithelioid cell neoplasm: Risk stratification and treatment strategies. Sarcoma.  https://doi.org/10.1155/2012/541626
  7. 7.
    Benson C, Vitfell-Rasmussen J, Maco M et al (2014) A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: The Royal Marsden Hospital experience. Anticancer Res 34:3663–3668Google Scholar
  8. 8.
    Varan A, Bayhan T, Kiratli H, Özoğul E, Kösemehmetoğlu K, Bulut E, Akyüz C (2017) An orbital perivascular epithelioid cell tumor in a 7-year-old boy: case report and review of the literature. JAAPOS 21(4):325–328Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Australian Craniofacial UnitAdelaideAustralia
  2. 2.Department of PathologyWomen and Children’s HospitalAdelaideAustralia
  3. 3.Department of NeurosurgeryRoyal Adelaide HospitalAdelaideAustralia

Personalised recommendations